Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/25407| Title: | Attention deficit hyperactivity disorder across the lifespan |
| Authors: | Camilleri, Nigel Saliba, Andrea Calleja Stafrace, Nadine |
| Keywords: | Attention-deficit hyperactivity disorder -- Children Attention-deficit hyperactivity disorder -- Chemotherapy Attention-deficit hyperactivity disorder -- Diagnosis Methylphenidate Attention-deficit disorder in adults |
| Issue Date: | 2017 |
| Publisher: | Malta College of Pharmacy Practice |
| Citation: | Camilleri, N., Saliba, A., & Calleja Stafrace, N. (2017). Attention deficit hyperactivity disorder across the lifespan. Journal of the Malta College of Pharmacy Practice, 23, 17-24. |
| Abstract: | This article is a research summary of published and non-published work pertaining to Attention Deficit Hyperactivity Disorders (ADHD). ADHD is one of the most common child mental health disorders and is under-recognised in children (5.29%) and adults (2.5%). ADHD is highly heritable with a multifactorial pattern of inheritance. Siblings and parents of a child with ADHD are 4 to 5 times more likely to have ADHD. Methylphenidate is the first line pharmacological treatment with a combined response (this includes trials of other licensed amphetamines) rate of 95%. All clinicians working in mental health should be aware of this disorder, comfortable diagnosing and treating people with ADHD. Young people with untreated ADHD are 5 times more likely to develop antisocial behaviour, substance abuse and other co morbid psychiatric disorders. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/25407 |
| Appears in Collections: | JMCPP, Issue 23 JMCPP, Issue 23 Scholarly Works - FacM&SPsy |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ISSUE23-5.pdf | 88.06 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.